rxstat › Shortages › Levothyroxine
Levothyroxine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Levothyroxine products are in shortage in Canada (2 of 31 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is May 8, 2026.
In shortage since
May 6, 2025
Est. full return
May 8, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-LEVOTHYROXINE
112MCG · TABLET · APOTEX INC
DIN 02550741 · since Apr 28, 2026, est. end May 8, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-LEVOTHYROXINE
200MCG · TABLET · APOTEX INC
DIN 02550806 · since May 6, 2025, est. end Jan 16, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
50MCG · TABLET · APOTEX INC
DIN 02550717 · ended Nov 13, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
112MCG · TABLET · APOTEX INC
DIN 02550741 · ended Nov 6, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
50MCG · TABLET · APOTEX INC
DIN 02550717 · ended Nov 6, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
137MCG · TABLET · APOTEX INC
DIN 02550776 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
125MCG · TABLET · APOTEX INC
DIN 02550768 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
88MCG · TABLET · APOTEX INC
DIN 02550733 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
125MCG · TABLET · APOTEX INC
DIN 02550768 · ended Oct 23, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
75MCG · TABLET · APOTEX INC
DIN 02550725 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
100MCG · TABLET · APOTEX INC
DIN 02534681 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-LEVOTHYROXINE
75MCG · TABLET · APOTEX INC
DIN 02550725 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Levothyroxine is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Levothyroxine is classified under “THYROID PREPARATIONS” (ATC H03AA).
Recent changes
Common questions
When will Levothyroxine be back in stock in Canada?
The latest manufacturer estimate is May 8, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Levothyroxine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.